| Drug Name: | Escitalopram (128196-01-0) |
|---|---|
| PubChem ID: | 146570 |
| SMILES: | CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F |
| InchiKey: | WSEQXVZVJXJVFP-FQEVSTJZSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 324.399 |
| LogP | : | 3.81298 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 3 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 36.26 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Haloperidol (52-86-8) | Akathisia | Synergistic | Escitalopram is an inhibitor of the cytochrome P450 isoenzyme CYP2D6, and may therefore inhibit haloperidol metabolism | A Review of its Use in the Management of Major Depressive Disorder |
| Haloperidol (52-86-8) | Parkinsonism | Synergistic | Escitalopram is an inhibitor of the cytochrome P450 isoenzyme CYP2D6, and may therefore inhibit haloperidol metabolism | A Review of its Use in the Management of Major Depressive Disorder |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category